In vitro analysis of type II endoleaks and aneurysm sac pressurization on longitudinal stent-graft displacement
- PMID: 21861753
- DOI: 10.1583/11-3469.1
In vitro analysis of type II endoleaks and aneurysm sac pressurization on longitudinal stent-graft displacement
Abstract
Purpose: To evaluate the effects of type II endoleaks and sac pressurization on stent-graft displacement following endovascular aneurysm repair (EVAR).
Methods: Experimental silicone infrarenal aneurysm (6-cm) models were "treated" with a Talent stent-graft deployed with 20-mm proximal and distal landing zones. Inflow and outflow vessels were created as part of the silicone model to control flow into the aneurysm sac. All aneurysm models were uniform, with a diameter neck of 31 mm, a neck length of 20 mm, and iliac artery diameters of 16 mm. The aortic model was secured in a water bath to a pulsatile pump under physiological conditions; the output phase ratio (%systole/%diastole) was set at 65/35 with a pump rate of 80 beats per minute. Commercially available bifurcated stent-grafts were then displaced in vitro utilizing a linear motion apparatus attached to a force gauge. The mean arterial pressure (MAP) and pulse pressure (PP) at the aortic inflow were 60.1 ± 3.1 and 38.3 ± 7.8 mmHg, respectively. Peak force to cause initial stent-graft migration with and without a type II endoleak was recorded and compared.
Results: In aneurysm sacs with no endoleak, the MAP and sac PP were 32 ± 6.4 and 6 ± 1.3 mmHg, respectively (p<0.01). In aneurysm sacs with a type II endoleak, the MAP and sac PP were 54.1 ± 9.7 and 16.1 ± 4.1 mmHg, respectively (p<0.02). Peak force to initiate migration was 16.0 ± 1.41 N (range 15-18) with no endoleak vs. 23.2 ± 2.2 N (range 20-25) in those with a type IIa endoleak and 23.5 ± 2.5 N (range 20-26) in those with a type IIb endoleak (p<0.001).
Conclusion: Type II endoleaks are associated with a significantly increased sac pressure. Increased sac pressurization from type II endoleaks results in a significantly greater force to displace a stent-graft longitudinally. Type II endoleaks may therefore inhibit migration and offer a benefit following EVAR; however, clinical correlation of these results is required.
Similar articles
-
Long-term outcomes of Palmaz stent placement for intraoperative type Ia endoleak during endovascular aneurysm repair.Ann Vasc Surg. 2011 Jan;25(1):120-6. doi: 10.1016/j.avsg.2010.08.004. Ann Vasc Surg. 2011. PMID: 21172587
-
The effect of injectable biocompatible elastomer (PDMS) on the strength of the proximal fixation of endovascular aneurysm repair grafts: an in vitro study.J Vasc Surg. 2010 Jul;52(1):152-8. doi: 10.1016/j.jvs.2010.01.026. Epub 2010 Mar 29. J Vasc Surg. 2010. PMID: 20347548
-
Long-term outcomes of secondary procedures after endovascular aneurysm repair.J Vasc Surg. 2010 Dec;52(6):1442-9. doi: 10.1016/j.jvs.2010.06.110. Epub 2010 Aug 17. J Vasc Surg. 2010. PMID: 20724099
-
Aneurysm sac pressure after EVAR: the role of endoleak.Eur J Vasc Endovasc Surg. 2007 Oct;34(4):432-41; discussion 442-3. doi: 10.1016/j.ejvs.2007.05.022. Epub 2007 Aug 1. Eur J Vasc Endovasc Surg. 2007. PMID: 17669670 Review.
-
Durability of endovascular infrarenal aneurysm repair: when does late failure occur and why?Semin Vasc Surg. 2009 Jun;22(2):102-10. doi: 10.1053/j.semvascsurg.2009.04.008. Semin Vasc Surg. 2009. PMID: 19573750 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous